RE:Remember.I agree Wallpaper2 I have been following some of the bigger shareholders and there are the nice names behind this company who are looking either for human trials or the rumour of a takeout by big pharma which could be back at the $25 to $30 a share price which is still a bargin for big pharma give low float.